- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
161
RAPID HBSAG DECLINE INSTEAD OF HBSAG ABSOLUTE LEVEL
CAN PREDICT HBSAG CLEARANCE IN COMMUNITY-BASED
UNTREATED CHRONIC HEPATITIS B COHORT
Hsin-Che Lin1, Jessica Liu2, Mei-Hung Pan1, Wen-
Juei Jeng3, Hwai-I Yang1 and REVEAL-HBV team, (1)
Genomics Research Center, Academia Sinica, (2)Perinatal
Epidemiology and Health Outcomes Research Unit, Division
of Neonatology, Department of Pediatrics, School of Medicine,
Stanford University and Lucile Packard Children’s Hospital,
Palo Alto, California, (3)Department of Gastroenterology and
Hepatology, Chang Gung Memorial Hospital, Linkou Branch,
Taiwan
Background: Spontaneous HBsAg clearance is regarded as
functional cure and the ultimate therapeutic endpoint in chronic
hepatitis B patients Previous tertiary hospital-based studies
have shown HBsAg decline >0.5 log10IU/mL in one year or >1
log10IU/mL in two years accompanied by absolute HBsAg level
<200 IU/mL can predict surface antigen clearance However,
they have not yet been validated by a community-based
cohort with relatively unstringent follow-up schedule This
study aimed to validate previous algorithms in a communitybased
cohort Methods: Participants from the REVEAL-HBV
cohort (n=4155) who had 3 or more quantitative HBsAg data
within 5 years prior to HBsAg clearance or patient’s last visit
were included Serum qHBsAg level was measured using
Roche Elecsys HBsAg II quant assay (range, 0 05–52,000 IU/
mL; Roche Diagnostics, Mannheim, Germany) Rapid HBsAg
decline was defined as HBsAg decline >0.5 log10IU/mL in 1
year or >1 log10IU/mL in 2 years. Sensitivity, specificity, PPV
and NPV were used to assess the performance on predicting
HBsAg clearance Statistic procedures were performed with
SAS 9.4. P-value less than .05 was considered significant.
Results: Among 707 CHB participants who met the inclusion
criteria, 41 participants achieved surface antigen clearance
during a median of 10 7 years follow-up The age at the entry
of the cohort [mean ±SD: 44 36±8 89 years vs 45 02±10 5
years; p=0 6465] and gender [male: 77 18% vs 78 05%; p=0
8972] between subjects with and without HBsAg clearance
were comparable The HBsAg levels in the clearance group
at all different time points were significantly lower (p<0.0001)
compared to the non-clearance group and the HBsAg decline
rate was greater [0 43 (0-0 72) vs 0 04 (-0 02-0 12) log10IU
/mL/year, p<0 0001] Similar to previous studies, combining
HBsAg level <200 IU/ml and a decline rate of 0 5 log10IU /
ml/year as a prediction algorithm (Sensitivity=0 4412,
Specificity=0.9792, PPV=0. 5172, NPV=0.972) showed
fairly good Specificity and NPV. Furthermore, using HBsAg
decline rate of 0 5 log10IU/ml/year alone achieved non-inferior
(Sensitivity=0.4412, Specificity=0.9792, PPV=0. 5172,
NPV=0 972) to the models of combining HBsAg decline rate
and HBsAg level Conclusion: HBsAg decline rate of 0 5
log10IU /mL/year alone can be used as a practical predictor for
HBsAg clearance in routine practice. |
|